Breakthrough: COVID-19 clinical trial in humans published

Determination of the Effectiveness of Chlorine Dioxide in the Treatment of COVID 19

At last, all the pharmaceutical trolls and pseudo-critics of MMS/chlorine dioxide can be countered with a citable study in an internationally recognized scientific journal. The internationally recognized  “Journal of Molcular and Genetic Medicine” published the above study in its issue Volume 15:S2, 2021. In it, the exceptional success of oral chlorine dioxide solutions in COVID-19 patients is confirmed in detail. It is also the first published human study as a medical product!

Introduction: The aim of this review is to determine the effectiveness of oral chlorine dioxide in the treatment of COVID 19.

Methods: Research on the mechanism of action of chlorine dioxide on viruses, oral absorption of water-soluble Cl02, and its toxicity was reviewed; a quasi-experimental study was conducted on the use of oral water-soluble chlorine dioxide in the treatment of 20 patients with active COVID19 infection, compared with a control group of 20 patients not treated with chlorine dioxide.

Results: To compare the effect in the experimental group versus the control group, a comparison test of proportions and their confidence intervals was performed for the general symptoms, and a paired test using the Wilcoxon-Mann-Whitney test (α: 95%) was performed for the VAS and Likert criteria . When the experimental group was compared with the control group on the seventh day after symptom manifestation, a significant difference was found in the experimental group compared with the control group for the symptoms of fever (p: 0000), cough (p: 0.0000), chills (p: 0.0000) and dyspnoea (p: 0.0006). When the visual-analogue comparison of the pain in the control group and in the experimental group was performed, it was found that all the items composing the scale significantly decreased in this group compared to the control group (p: 0.0000; p:00017). On day 14 after the demonstration, the difference was even greater (p:0.000 ; p:0.0043). When the two groups (control and experimental) were evaluated in the laboratory, a difference was found in the values of the parameters PC Reactive at day 7 (p: 0.0001) and DH Lactate (0.0036), with higher values for the experimental group; Dimero-D at day 7 (p: 0.0194) and at day 14 (p:0.0029) ; difference was found in all parameters. The overall results (p <0.05) support the hypothesis that chlorine dioxide is effective in the treatment of COVID19.

CONCLUSION: Chlorine dioxide is effective in the treatment of COVID19 and the mechanisms of action by which it achieves this are proposed in this work. We recommend that further research be conducted. We recommend that double-blind studies be conducted and more in-depth studies on the toxicological safety and therapeutic efficacy of chlorine dioxide in epidemiologically significant diseases be conducted in the near future.

Scroll to Top